Скачать или смотреть What Is Blood Convalescent Plasma Therapy?

The U.S. Food and Drug Administration confirmed that an Emergency Use Authorization was granted for the use of Covid-19 convalescent plasma for the treatment of hospitalized patients, before an expected announcement by President Donald Trump.

Covid-19 convalescent plasma is collected from individuals whose plasma contains anti-SARS-CoV-2 antibodies.

The EUA was granted based on a review of historical evidence using convalescent plasma in prior outbreaks of respiratory viruses, certain preclinical evidence, results from small clinical trials conducted during the current outbreak and data from the ongoing National Convalescent Plasma Expanded Access Protocol, according to a letter posted on the FDA website.

Adequate and well-controlled randomized trials remain necessary for a definitive demonstration of efficacy and to determine the appropriate patient populations and optimal product attributes.

Trump is expected to announce the emergency authorization at a press conference later Sunday.

Subscribe to our YouTube channel: https://bit.ly/2TwO8Gm

QUICKTAKE ON SOCIAL:
Follow QuickTake on Twitter: twitter.com/quicktake
Like QuickTake on Facebook: facebook.com/quicktake
Follow QuickTake on Instagram: instagram.com/quicktake
Subscribe to our newsletter: https://bit.ly/2FJ0oQZ
Email us at [email protected]

QuickTake by Bloomberg is a global news network delivering up-to-the-minute analysis on the biggest news, trends and ideas for a new generation of leaders.